Do peripheral killer cells differentiate between asthma patients with or without fixed airway obstruction?
Peripheral killer cell numbers or functions do not differentiate between asthma patients with or without fixed airway obstruction.
MHGST suppressed neutrophilic lung inflammation, a hallmark of ALI, which was associated with the activation of anti-inflammatory Nrf2 and the suppression of pro-inflammatory NF-κB. Our results suggest that MHGST has a therapeutic potential against ALI.